J Clin Oncol 2017 Jan 17
Radiation-Induced Heart Disease After Breast Cancer Treatment: How Big a Problem, and How Much Can-and Should-We Try to Reduce It?
Related Questions
What normalization do you choose, what is your preferred target volume coverage, and how do you assess for homogeneity and heterogeneity?
New answer by Radiation Oncologist at Lake Huron Medical Center (September 27, 2021)
Agree with @Sushil Beriwal and @Chirag S. Shah, but I do contour the breast tissue, that way there is an actual target. If you use the 95% isodose line to create the target, t...
New comment by Radiation Oncologist at NorthShore University Health System ( September 8, 2023)
Agree, sound logic. I reserve INM RT for large medial lesions with positive axilla. SN mapping very rarely is positive for INM nodes.
If the dose to these OARs deviates from goal by a significant margin, how do you approach changing the treatment plan, accordingly?
New comment by Radiation Oncologist at UNC School of Medicine ( September 12, 2023)
I agree with Dr. @Recht's thoughtful answer. I agree that a local/regional recurrence is usually more impactful than most of our toxicities. My colleagues often hear me say, &...